2011;63:84C95

2011;63:84C95. MHC I but also PD-L1. Importantly, F2 enhanced the antigen presenting capacity of dendritic cells, whilst reducing the suppressive activity of myeloid-derived suppressor cells. In BI605906 conclusion, these data suggest that intratumoral delivery of mRNA encoding soluble proteins, such as F2, can modulate the tumor microenvironment, leading to effective antitumor T cell responses, which can be further potentiated through combination therapy. generated fusokine. Therefore, we quantified the expression of the type I IFN-inducible gene in splenocytes cultured for 6 hours with the supernatants or with varying amounts of recombinant IFN-. qPCR analysis demonstrated that this CT-values obtained upon treatment of splenocytes with F2 supernatants was comparable to those obtained upon treatment of splenocytes with 17.1 1.7 ng/ml (n = 3) recombinant IFN- (Fig. ?(Fig.1B).1B). To investigate the capacity of the fusokine to neutralize TGF- we used the TGF- BI605906 reporter HEK293T cell line, which expresses eGFP under the control of a TGF- responding promoter [11]. Indeed, higher eGFP expression was observed when the cell line was cultured with increased amounts of recombinant TGF- (Fig. ?(Fig.1C).1C). This was greatly reduced BI605906 by the presence of F2 in the supernatants (Fig. ?(Fig.1D).1D). Additionally, the neutralization capacity of the BI605906 fusokine was compared to a commercially available neutralizing anti-TGF- antibody. The capacity of F2 to neutralize TGF- was comparable with 20 ng/ml of the commercially available anti-TGF- antibody (Fig. ?(Fig.1D).1D). These results are consistent with the quantity of F2 estimated based on the expression of the IFN-inducible gene (Fig. ?(Fig.1B).1B). Together, these data demonstrate that this mRNA encoding the F2 fusokine is usually translated into a functional protein. Open in a separate window Physique 1 F2 mRNA is usually translated to a functional protein(A) Schematic representation of the F2 mRNA construct. (B) Splenocytes were cultured for 5 hours in F2, control (Ctrl) supernatants or exposed to increasing amounts of recombinant IFN-. qPCR was performed to determine expression. The graph depicts the amount of fusokine (pg/ml). The quantity was determined based on the expression of upon treatment with recombinant IFN- and normalized to 2?ct for (n=3). (C) The TGF- reporter HEK293T cell line was cultured for 24 hours in 0 to 400 pg/ml of recombinant TGF- (rec. TGF-). The histogram overlay depicts the eGFP expression. Representative plots are shown (n=4) (D) The TGF- reporter HEK293T cell line was cultured for 24 hours in F2, Ctrl supernatants or exposed to 20 ng of a commercial available anti-TGF- antibody, and supplemented with 200 pg of recombinant TGF-. The histogram overlay depicts the eGFP expression. Representative plots are shown (n=3). The F2 fusokine modulates myeloid cells to improve CD8+ T cell responses To analyze the effect of F2 on DCs, we cultured them for 48 hours in supernatants of HEK293T cells that were electroporated with 20 g of F2 or eGFP mRNA. DCs cultured with 20 ng/ml of recombinant IFN- or activated for 4 hours with 100 ng/ml LPS were used as a control. Flow cytometry analysis revealed that DCs cultured with F2 displayed an enhanced expression of co-stimulatory and antigen-presenting molecules (Fig. ?(Fig.2A),2A), and secreted pro-inflammatory cytokines (Fig. ?(Fig.2B).2B). To further evaluate the functionality of these DCs, we performed an stimulation of OT-I cells. We exhibited that DCs pulsed with SIINFEKL peptide and cultured in the presence Thymosin 4 Acetate of F2 lead to enhanced production of IFN- by antigen-specific CD8+ OT-I cells (Fig. 2C-D). We next analyzed the effect of F2 on MDSCs. To that end, MDSCs that closely resemble those found within tumors were generated [12, 13]. Of note, these MDSCs produce high levels of TGF- (Fig. ?(Fig.2E).2E). The MDSCs were cultured for 3 days in supernatants of HEK293T cells that were electroporated with 20 g of F2 or eGFP mRNA. We found that MDSCs cultured in the presence of F2 were no longer able to fully suppress the functionality of CD8+ T cells as shown by the ability of these T cells to produce IFN- BI605906 (Fig. ?(Fig.2F).2F). This might be.